Search filters

List of works by David R Gandara

A Phase 1/1b Study Evaluating Trametinib Plus Docetaxel or Pemetrexed in Patients With Advanced Non-Small Cell Lung Cancer

scientific article published on 19 November 2016

A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas ⬇️

scientific article published on February 3, 2012

A Phase II Study of Halichondrin B Analog Eribulin Mesylate (E7389) in Patients with Advanced Non-small Cell Lung Cancer Previously Treated with a Taxane: A California Cancer Consortium Trial ⬇️

scientific article published on March 1, 2012

A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer

scientific article published in February 2004

A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer

scientific article published on 28 August 2013

A Pilot Trial of Cisplatin/Etoposide/Radiotherapy Followed by Consolidation Docetaxel and the Combination of Bevacizumab (NSC-704865) in Patients With Inoperable Locally Advanced Stage III Non-Small-Cell Lung Cancer: SWOG S0533

scientific article published on 9 January 2015

A Practical Guide of the Southwest Oncology Group to Measure Malignant Pleural Mesothelioma Tumors by RECIST and Modified RECIST Criteria ⬇️

scientific article published on March 1, 2011

A microdosing approach for characterizing formation and repair of carboplatin-DNA monoadducts and chemoresistance

scientific article

A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma

scientific article published in September 2008

A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701).

scientific article

A phase I study of oxaliplatin in combination with gemcitabine: correlation of clinical outcome with gene expression

scientific article

A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors ⬇️

scientific article published on May 28, 2013

A phase II study of cell cycle inhibitor UCN-01 in patients with metastatic melanoma: a California Cancer Consortium trial

scientific article published on 22 October 2010

A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer

scientific article published on 24 January 2009

A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer

scientific article published in February 2007

A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma

scientific article published on 06 June 2019

A phase II study of vascular endothelial growth factor trap (Aflibercept, NSC 724770) in patients with myelodysplastic syndrome: a California Cancer Consortium Study.

scientific article published on 21 September 2016

A phase II trial of gefitinib and pegylated IFNα in previously treated renal cell carcinoma.

scientific article published on 23 March 2011

A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study

scientific article published on March 2009

A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study

scientific article published on November 2008

A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases

scientific article published on March 2006

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer

scientific article

Aberrant Regulation of the MRP3 Gene in Non-small Cell Lung Carcinoma ⬇️

scientific article published on January 1, 2012

Acquired resistance to targeted therapies against oncogene-driven non-small-cell lung cancer: approach to subtyping progressive disease and clinical implications

scientific article published on 12 October 2013

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

scientific article

Adjuvant and neoadjuvant treatments for NSCLC.

scientific article

Adjuvant chemotherapy of stage I non-small cell lung cancer in North America

scientific article published on July 2007

Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial

scientific article published on 9 November 2017

Adjuvant treatment of stage IB NSCLC: the problem of stage subset heterogeneity.

scientific article published on April 2008

Aflibercept (VEGF Trap) in Inoperable Stage III or Stage IV Melanoma of Cutaneous or Uveal Origin ⬇️

scientific article published on August 31, 2011

Algorithm for codevelopment of new drug-predictive biomarker combinations: accounting for inter- and intrapatient tumor heterogeneity

scientific article

An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach.

scientific article published on 8 June 2017

An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California

scientific article published in September 2004

Analysis of ribonucleotide reductase M2 mRNA levels in patient samples after GTI-2040 antisense drug treatment

scientific article

Anti-tumor activity of osimertinib, an irreversible mutant-selective EGFR tyrosine kinase inhibitor, in NSCLC harboring EGFR Exon 20 Insertions

scientific article published on 26 February 2018

Antisense oligonucleotides in the treatment of non-small-cell lung cancer

scientific article published on January 2003

Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer

scientific article published in December 2010

Aurora kinase inhibitors: a new class of targeted drugs in cancer

scientific article published on September 2006

Aurora kinases as anticancer drug targets

scientific article

Bevacizumab: optimal dose, schedule, and duration of therapy.

scientific article

Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier

scientific article published on March 2009

Biomarkers of DNA repair and related pathways: significance in non-small cell lung cancer ⬇️

scientific article published on March 1, 2011

Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327).

scientific article published in November 2006

Bortezomib Plus Docetaxel in Advanced Non-small Cell Lung Cancer and Other Solid Tumors: A Phase I California Cancer Consortium Trial

Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).

scientific article published on October 2011

Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339)

scientific article

Bortezomib-based combinations in the treatment of non-small-cell lung cancer

scientific article

Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform

scientific article

Bronchioloalveolar carcinoma: a model for investigating the biology of epidermal growth factor receptor inhibition

scientific article published in June 2004

CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapy

scientific article

CT perfusion imaging of lung cancer: benefit of motion correction for blood flow estimates

article

Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer

scientific article

Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium ⬇️

scientific article published on July 23, 2012

Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma ⬇️

scientific article published on March 25, 2003

Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study

scientific article

Challenges and approaches to implementing master/basket trials in oncology

scientific article published on 01 July 2019

Challenges in Facing the Lung Cancer Epidemic and Treating Advanced Disease in Latin America

scientific article published on 5 June 2016

Chemotherapy for brain metastases in small-cell lung cancer

scientific article published on January 2008

Chemotherapy outcomes by histologic subtypes of non-small-cell lung cancer: analysis of the southwest oncology group database for antimicrotubule-platinum therapy

scientific article

Chip-based nLC-TOF-MS is a highly stable technology for large-scale high-throughput analyses

scientific article published on 23 March 2013

Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry

scientific article

Clinicopathologic Features of Advanced Squamous NSCLC.

scientific article published on 10 June 2016

Common arm comparative outcomes analysis of phase 3 trials of cisplatin + irinotecan versus cisplatin + etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology G

scientific article

Comparison of Platinum-Based Chemotherapy in Patients Older and Younger than 70 Years: An Analysis of Southwest Oncology Group Trials 9308 and 9509 ⬇️

scientific article published on January 1, 2011

Computer-assisted image analysis of bronchioloalveolar carcinoma

scientific article

Concurrent chemoradiation strategies in the management of unresectable stage III non-small-cell lung cancer.

scientific article published on May 2002

Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019.

scientific article

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop

scientific article published on October 2010

Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504 ⬇️

scientific article published on May 15, 2003

Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?

scientific article published on March 2008

Cooperative group research efforts in lung cancer 2008: focus on advanced-stage non-small-cell lung cancer

scientific article

Cooperative group research efforts in lung cancer: focus on early-stage non-small-cell lung cancer

scientific article published on January 2008

Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress

scientific article

Cooperative group research endeavors in small-cell lung cancer: current and future directions

scientific article published in September 2009

Current and Emergent Therapy Options for Advanced Squamous-Cell Lung Cancer

scientific article

Current and future therapeutic approaches in locally advanced (stage III) non-small cell lung cancer

scientific article

Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial

scientific article

Design of a Phase III Clinical Trial with Prospective Biomarker Validation: SWOG S0819 ⬇️

scientific article published on May 16, 2012

Developing targeted therapies for lung cancer.

scientific article published in November 2003

Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy

scientific article published in 2015

Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.

scientific article

Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database

scientific article published on 20 October 2015

Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials

scientific article

Docetaxel in non-small cell lung cancer: a review

scientific article

Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study

scientific article published in June 2007

Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC.

scientific article

Dual inhibition: combining epidermal growth factor-targeted therapies in non-small-cell lung cancer

scientific article published on July 2007

EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer

scientific article published in December 2009

EGFR tyrosine kinase inhibitors in squamous cell lung cancer.

scientific article published on 5 July 2015

Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement

scientific article published in July 2005

Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer

scientific article published in February 2002

Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines

scientific article

Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non-Small-Cell Lung Cancer

scientific article

Efficacy and toxicity differences in lung cancer populations in the era of clinical trials globalization: the ‘common arm’ approach ⬇️

scientific article published on December 1, 2012

Enhancement of radiation cytotoxicity by UCN-01 in non-small cell lung carcinoma cells

scientific article

Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs

scientific article published on May 2004

Enhancing the clinical activity of sorafenib through dose escalation: rationale and current experience ⬇️

scientific article published on March 1, 2011

Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012

scientific article

Epidermal growth factor receptor inhibition in lung cancer: status 2012.

scientific article published on March 2013

Epidermal growth factor receptor inhibitors plus chemotherapy in non-small-cell lung cancer: biologic rationale for combination strategies

scientific article published on February 2007

Epidermal growth factor receptor tyrosine kinase inhibitors plus chemotherapy: case closed or is the jury still out?

scientific article published on 25 July 2005

Erlotinib and vinorelbine in advanced malignant solid tumors: a phase I study

scientific article published on 18 April 2007

Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy

scientific article

Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials

scientific article published in December 2005

Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study

scientific article

Evolution and Increasing Complexity of the Therapeutic Landscape in Advanced Non-Small-cell Lung Cancer

scientific article published on 24 December 2016

Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012 ⬇️

scientific article published on March 1, 2010

Evolving treatment algorithms for advanced non-small-cell lung cancer: 2009 looking toward 2012.

scientific article published in November 2009

FASTACT-2: but don't act too fast ⬇️

scientific article published on June 17, 2013

Feasibility study of intra-patient sorafenib dose-escalation or re-escalation in patients with previously treated advanced solid tumors

scientific article

First-generation epidermal growth factor receptor inhibitors in non-small cell lung cancer: clinical impact of the epidermal growth factor receptor fluorescence in situ hybridization assay

scientific article published on June 2008

Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.

scientific article published in April 2006

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study

scientific article

Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.

scientific article

Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trial

scientific article published in September 2004

Genotyping and Genomic Profiling of Non–Small-Cell Lung Cancer: Implications for Current and Future Therapies ⬇️

scientific article published on February 11, 2013

Geospatial Resolution of Human and Bacterial Diversity with City-Scale Metagenomics

scientific article

Geospatial Resolution of Human and Bacterial Diversity with City-Scale Metagenomics

article

HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial

scientific article published on May 2002

Histology-Related Associations of ERCC1, RRM1, and TS Biomarkers in Patients with Non–Small-Cell Lung Cancer: Implications for Therapy ⬇️

scientific article published on May 1, 2013

Identification of F-box/LLR-repeated protein 17 as potential useful biomarker for breast cancer therapy

scientific article

Impact of an Interactive On-line Tool on Therapeutic Decision-Making for Patients with Advanced Non-Small-Cell Lung Cancer

scientific article published on 25 February 2015

Impact of disease progression date determination on progression‐free survival estimates in advanced lung cancer ⬇️

scientific article published on March 20, 2012

Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials

scientific article

In Reply

In Reply

Incorporating bortezomib into the treatment of lung cancer

scientific article published on August 2007

Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy

scientific article

Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study

scientific article published on 5 July 2005

Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment

scientific article published on 26 August 2016

Independent review of interstitial lung disease associated with death in TRIBUTE (paclitaxel and carboplatin with or without concurrent erlotinib) in advanced non-small cell lung cancer

scientific article published on June 2007

Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making

scientific article

Integrated Metabolomics and Proteomics Highlight Altered Nicotinamide- and Polyamine Pathways in Lung Adenocarcinoma

scientific article published on 3 January 2017

Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer

scientific article

Integration of the proteasome inhibitor PS-341 (Velcade) into the therapeutic approach to lung cancer

scientific article

Intercalated erlotinib-docetaxel dosing schedules designed to achieve pharmacodynamic separation: results of a phase I/II trial

scientific article published on December 2011

Intercalation of erlotinib and pemetrexed in the treatment of non-small cell lung cancer

scientific article published on January 2010

Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial

scientific article

Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separation

scientific article

Interstitial lung disease associated with epidermal growth factor receptor tyrosine kinase inhibitor therapy in non-small-cell lung carcinoma.

scientific article published on December 2006

Investigation of metabolomic blood biomarkers for detection of adenocarcinoma lung cancer

scientific article

Is inhibition of cancer angiogenesis and growth by paclitaxel schedule dependent?

scientific article published on October 2004

Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics

scientific article

Large-scale screening and molecular characterization of EML4-ALK fusion variants in archival non-small-cell lung cancer tumor specimens using quantitative reverse transcription polymerase chain reaction assays

scientific article published on January 2014

Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504).

scientific article published in September 2006

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

scientific article

Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003

scientific article published on 08 September 2008

Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.

scientific article

Lung-MAP--framework, overview, and design principles

scientific article

Metabolomic markers of altered nucleotide metabolism in early stage adenocarcinoma

scientific article

Modern Methods for Delineating Metagenomic Complexity

scientific article

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies

scientific article published on 21 March 2018

Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma ⬇️

scientific article published on June 4, 2012

Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer

scientific article published in July 2015

Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapy

scientific article

Natural history of stage I non-small cell lung cancer: implications for early detection

scientific article published on 15 May 2007

Non-Small-Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy

scientific article published on July 2015

Non-small-cell lung cancer progression after first-line chemotherapy

scientific article

Non-small-cell lung cancer: then and now.

scientific article published on 11 February 2013

O.02: Plasma Next Generation Sequencing of Over 5,000 Advanced Non-Small Cell Lung Cancer Patients With Clinical Correlations

scientific article

Optimal adjuvant therapy for non-small cell lung cancer--how to handle stage I disease

scientific article published on March 2007

Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial

scientific article published in January 2009

Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer

scientific article published on 19 March 2014

Overcoming barriers to cancer clinical trial accrual: impact of a mass media campaign

scientific article published in January 2008

Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe

scientific article

PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer

scientific article

Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 Trials

scientific article published on 06 July 2017

Patient-Derived Xenografts for Investigation of Acquired Resistance in Oncogene-Driven Cancers: Building a Better Mousetrap

scientific article

Pharmacodynamic separation of epidermal growth factor receptor tyrosine kinase inhibitors and chemotherapy in non-small-cell lung cancer

scientific article published on May 2006

Pharmacodynamics (PD) and pharmacokinetics (PK) of E7389 (eribulin, halichondrin B analog) during a phase I trial in patients with advanced solid tumors: a California Cancer Consortium trial

scientific article

Pharmacogenomic approaches to individualizing chemotherapy for non-small-cell lung cancer: current status and new directions

scientific article published on January 2008

Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the national cancer institute organ dysfunction working group ⬇️

scientific article published on August 1, 2003

Phase 2 trial of Linifanib (ABT-869) in patients with advanced non-small cell lung cancer

scientific article published on August 2011

Phase I Trial of Arginine Deprivation Therapy with ADI-PEG 20 Plus Docetaxel in Patients with Advanced Malignant Solid Tumors

scientific article published on 4 March 2015

Phase I Trial of Cediranib in combination with cisplatin and pemetrexed in chemo naive patients with unresectable malignant pleural mesothelioma (SWOG S0905).

scientific article

Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial

scientific article published on 12 September 2002

Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors

scientific article

Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study

scientific article published on August 2004

Phase I study of two different schedules of bortezomib and pemetrexed in advanced solid tumors with emphasis on non-small cell lung cancer

scientific article published in December 2007

Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study ⬇️

scientific article

Phase I trial of edatrexate in advanced breast and other cancers

scientific article

Phase I trial of gemcitabine and paclitaxel in advanced solid tumors

scientific article

Phase I trial of high-dose tamoxifen in combination with cisplatin in patients with lung cancer and other advanced malignancies

scientific article published in January 2003

Phase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancer

scientific article

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A

scientific article published in 2022

Phase II Study of the AKT Inhibitor MK-2206 plus Erlotinib in Patients with Advanced Non-Small Cell Lung Cancer Who Previously Progressed on Erlotinib

scientific article

Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor ()-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California

Phase II Trial of Paclitaxel, Carboplatin, and Topotecan with G-CSF Support in Previously Untreated Patients with Extensive Stage Small Cell Lung Cancer: Southwest Oncology Group 9914

article published in 2006

Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia

scientific article published in January 2008

Phase II randomized trial of bevacizumab versus bevacizumab and thalidomide for relapsed/refractory multiple myeloma: a California Cancer Consortium trial ⬇️

scientific article published on April 26, 2011

Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342

scientific article

Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer

scientific article

Phase II study of Aflibercept (VEGF-Trap) in patients with recurrent or metastatic urothelial cancer, a California Cancer Consortium Trial

scientific article

Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097).

scientific article

Phase II study of belinostat (PXD101), a histone deacetylase inhibitor, for second line therapy of advanced malignant pleural mesothelioma

scientific article published on January 2009

Phase II study of cediranib in patients with malignant pleural mesothelioma: SWOG S0509

scientific article

Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.

scientific article published in November 2006

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study

scientific article published on June 2007

Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.

scientific article

Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer: a California Cancer Consortium Trial

scientific article published in August 2008

Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.

scientific article published on 13 April 2009

Phase II study of vorinostat for treatment of relapsed or refractory indolent non-Hodgkin's lymphoma and mantle cell lymphoma

scientific article

Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study ⬇️

scientific article published on 09 October 2010

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer

scientific article

Phase II trial of carboplatin, paclitaxel, cetuximab, and bevacizumab followed by cetuximab and bevacizumab in advanced nonsquamous non-small-cell lung cancer: SWOG S0536

scientific article

Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.

scientific article

Phase II trial of gemcitabine plus irinotecan in patients with esophageal cancer: a Southwest Oncology Group (SWOG) trial

scientific article

Phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancer

scientific article

Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426.

scientific article

Phase III study of gemcitabine and cisplatin with or without aprinocarsen, a protein kinase C-alpha antisense oligonucleotide, in patients with advanced-stage non-small-cell lung cancer

scientific article

Phase III trial of irinotecan/cisplatin compared with etoposide/cisplatin in extensive-stage small-cell lung cancer: clinical and pharmacogenomic results from SWOG S0124.

scientific article

Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.

scientific article published on 31 March 2008

Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.

scientific article published in December 2005

Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab

scientific article published on November 2008

Population-based maximum tolerated dose of irinotecan and carboplatin

scientific article

Population-based phase I trial of irinotecan and epirubicin

scientific article

Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited

scientific article

Postprogression Prolongation of Survival in EGFR-Mutated Lung Cancer: Reconciling the ASPIRATION and IMPRESS Trials

scientific article published on 30 December 2015

Preclinical Evaluation of MET Inhibitor INC-280 With or Without the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Non-Small-Cell Lung Cancer

scientific article published on 21 November 2016

Predictive molecular markers: has the time come for routine use in lung cancer?

scientific article published on March 2004

Predictors of survival for younger patients less than 50 years of age with non-small cell lung cancer (NSCLC): a California Cancer Registry analysis

scientific article published on 6 May 2014

Premedication strategy for weekly paclitaxel

scientific article published in January 2002

Prognostic and predictive value of epidermal growth factor receptor tyrosine kinase domain mutation status and gene copy number for adjuvant chemotherapy in non-small cell lung cancer

scientific article

Proteasome inhibition in small-cell lung cancer: preclinical rationale and clinical applications

scientific article

Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy

scientific article published on February 2004

Proteomic profiling of lung adenocarcinoma indicates heightened DNA repair, antioxidant mechanisms and identifies LASP1 as a potential negative predictor of survival

scientific article published on 27 October 2016

Racial Disparities on the Use of Invasive and Noninvasive Staging in Patients with Non-small Cell Lung Cancer ⬇️

scientific article published on November 1, 2010

Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment

scientific article published on November 2006

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial

scientific article published on 24 July 2009

Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results of NCI/C

Randomized Phase 2 Trial of Pharmacodynamic Separation of Pemetrexed and Intercalated Erlotinib Versus Pemetrexed Alone for Advanced Nonsquamous, Non-small-cell Lung Cancer

scientific article

Randomized Trial of Oral Cyclophosphamide and Veliparib in High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers, or BRCA-Mutant Ovarian Cancer

scientific article

Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer

scientific article published on 21 March 2016

Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel

scientific article

Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer

scientific article published in March 2006

Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.

scientific article

Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer

scientific article

Relevance of platinum-sensitivity status in relapsed/refractory extensive-stage small-cell lung cancer in the modern era: a patient-level analysis of southwest oncology group trials

scientific article

Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer".

scientific article published in May 2015

Resection of multifocal non-small cell lung cancer when the bronchioloalveolar subtype is involved

scientific article published in November 2003

SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay

scientific article published on 24 December 2015

SWOG S0722: phase II study of mTOR inhibitor everolimus (RAD001) in advanced malignant pleural mesothelioma (MPM)

scientific article

Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: rationale for pharmacodynamic separation

scientific article published on November 2007

Scientific Advances in Lung Cancer 2015.

scientific article published on 21 March 2016

Second-line treatment for advanced-stage non-small-cell lung cancer: current and future options.

scientific article published on May 2006

Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).

scientific article published in July 2006

Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care

scientific article

Small Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?

scientific article published on 29 January 2016

Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).

scientific article published on 13 January 2018

Sorafenib in Platinum-Treated Patients with Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group (SWOG 0435) Phase II Trial ⬇️

scientific article published on November 1, 2010

Southwest Oncology Group S0802: a randomized, phase II trial of weekly topotecan with and without ziv-aflibercept in patients with platinum-treated small-cell lung cancer

scientific article

Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.

scientific article

Southwest Oncology Group: two decades of experience in non-small cell lung cancer

scientific article

Southwestern Oncology Group Phase II Trial (S0526) of Pemetrexed in Bronchioloalveolar Carcinoma Subtypes of Advanced Adenocarcinoma ⬇️

scientific article published on February 14, 2013

Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-Mutated Lung Cancer

scientific article

Summary report 7th Annual Targeted Therapies of the Treatment of Lung Cancer

scientific article

Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial

scientific article

Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry

scientific article published on 9 April 2015

Targeted therapies in non-small-cell lung cancer: a paradigm in evolution.

scientific article published in January 2008

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

scientific article

Targeting of MEK in lung cancer therapeutics

scientific article published on 20 March 2015

The AKT inhibitor perifosine in biochemically recurrent prostate cancer: a phase II California/Pittsburgh cancer consortium trial

scientific article

The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations

scientific article published in 2022

The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016.

scientific article published on 20 May 2016

The Tissue Is the Issue: Personalized Medicine for Non-Small Cell Lung Cancer ⬇️

scientific article published on 05 October 2010

The continuing role of chemotherapy for advanced non-small cell lung cancer in the targeted therapy era.

scientific article published on October 2013

The cyclin-dependent kinase inhibitor UCN-01 plus cisplatin in advanced solid tumors: a California cancer consortium phase I pharmacokinetic and molecular correlative trial

scientific article published on June 2005

The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: a California Cancer Consortium Phase I study

scientific article

Theory Meets Practice for Immune Checkpoint Blockade in Small-Cell Lung Cancer

scientific article published on 6 September 2016

Therapeutic Strategies for Combined-Modality Therapy of Locally Advanced-Stage Non–Small-Cell Lung Cancer: Rationale for Consolidation Docetaxel Therapy

Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapy

scientific article

Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group

scientific article

Tirapazamine plus carboplatin and paclitaxel in advanced malignant solid tumors: a california cancer consortium phase I and molecular correlative study

scientific article published in October 2003

Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia

scientific article (publication date: February 2002)

Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma

scientific article published on 17 November 2016

Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial

scientific article published on May 2004

Trastuzumab plus docetaxel in HER2/neu-positive non-small-cell lung cancer: a California Cancer Consortium screening and phase II trial

scientific article

Treatment of extensive small cell lung cancer

scientific article published on April 2004

Treatment options for patients with advanced-stage non-small-cell lung cancer: who are the "elderly" and who are the "unfit"?

scientific article published in November 2005

Trimodality therapy for superior sulcus non-small cell lung cancer: Southwest Oncology Group-Intergroup Trial S0220

scientific article

Unfavorable therapeutic index of cisplatin/gemcitabine/vinorelbine in advanced non-small-cell lung cancer

scientific article

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer

scientific article

Paulina is supported by:

About Paulina

Help